Senexon-S

Manufacturer: RUGBY LABORATORIES | Pharbest Pharmaceuticals, Inc.
Effective date: 2024-12-19
Label type: HUMAN OTC DRUG LABEL
Version: 3
Source: full-release
Hydrated at: 2026-06-01 00:47:21

Label at a glance#

ProductSenexon-S

Active ingredientSENNOSIDES, DOCUSATE SODIUM

Label structure9 sections

Indications and uses

relieves occasional constipation (irregularity) generally produces a bowel movement in 6-12 hours

Dosage and administration

take preferably at bedtime or as directed by a doctor age starting dosage maximum dosage adults and children 12 years and over 2 tablets once a day 4 tablets twice a day children 6 to under 12 years 1 tablet once a day 2 tablets twice a day children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day children under 2 years ask a doctor ask a doctor

Storage and handling

each tablet contains: calcium 10 mg, sodium 5 mg, Very Low Sodium store at 20-25°C (68-77°F); excursions permitted between 15-30 o C (59-86 o F)

Contacts and useful links#

PhonePoison Help1-800-222-1222

PhoneLabel contact(866)-562-2756

Label contents#

Full prescribing information#

Active Ingredients (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Docusate Sodium 50 mg

Sennosides 8.6 mg

Purpose

OTC - PURPOSE SECTION

Stool Softener

Laxative

Uses

INDICATIONS & USAGE SECTION

relieves occasional constipation (irregularity)
generally produces a bowel movement in 6-12 hours

Warnings

WARNINGS SECTION

Do not use

OTC - DO NOT USE SECTION

if you are now taking mineral oil, unless directed by a doctor
laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

stomach pain
nausea
vomiting
noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if

OTC - STOP USE SECTION

you have rectal bleeding or fail to have a bowel movement after the use of a laxative.

These may indicate a serious condition.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

DOSAGE & ADMINISTRATION SECTION

take preferably at bedtime or as directed by a doctor

age	starting dosage	maximum dosage
adults and children 12 years and over	2 tablets once a day	4 tablets twice a day
children 6 to under 12 years	1 tablet once a day	2 tablets twice a day
children 2 to under 6 years	1/2 tablet once a day	1 tablet twice a day
children under 2 years	ask a doctor	ask a doctor

Other information

STORAGE AND HANDLING SECTION

each tablet contains: calcium 10 mg, sodium 5 mg, Very Low Sodium
store at 20-25°C (68-77°F); excursions permitted between 15-30^oC (59-86^oF)

Inactive ingredients

INACTIVE INGREDIENT SECTION

croscarmellose sodium, D&C Yellow# 10, dicalcium phosphate, FD&C Yellow #6, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, sodium benzoate, talc, titanium dioxide

Questions or comments?

OTC - QUESTIONS SECTION

(866)-562-2756 (Mon-Fri 8 AM to 4 PM EST)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

RUGBY

NDC 0536-1247-10

Compare to the active ingredients in Senokot-S^®*

Senexon-S

Docusate Sodium, 50 mg

Sennosides, 8.6 mg

Natural Vegetable

Laxative Ingredient

+ Stool Softener

1000 TABLETS

Rugby Senexon-S 1000 ct. Product Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1248013	Senexon-S 50 MG / 8.6 MG Oral Tablet	PSN	3
998740	sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet	PSN	3
1248013	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Senexon S]	SBD	3
998740	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SCD	3
998740	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SY	3
1248013	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Senexon S]	SY	3
1248013	Senexon-S (docusate sodium 50 MG / sennosides, USP 8.6 MG) Oral Tablet	SY	3

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c6f86816-7da6-43ea-8c25-ac9758311cc5	Product name	1	20220118
252e11b6-1a9a-4283-a242-df2c129c496d	Product name	3	20170717

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0536-1247-01	Senexon-S	100 in 1 BOTTLE, PLASTIC	TABLET, FILM COATED	100		3
0536-1247-10	Senexon-S	1000 in 1 BOTTLE, PLASTIC	TABLET, FILM COATED	1000		3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0536-1247	SENEXON-S (DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG) TABLET, FILM COATED [RUGBY LABORATORIES]	3	Current NDC, Legacy NDC, 2 package rows	20241222_2e758ff1-3083-4245-8f58-1c47b042bfdd.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0536-1247-01	EA - Each	0536-1247	d7ebf6c0-94d1-4058-a337-8a1c4cdc054c	1	2019-11-12
0536-1247-10	EA - Each	0536-1247	fc120350-f269-411f-a810-65f8d76772f0	1	2019-11-12

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

Senexon-S
Docusate Sodium 50mg and Sennosides 8.6mg
SENNOSIDES
DOCUSATE SODIUM
DOCUSATE
CROSCARMELLOSE SODIUM
D&C YELLOW NO. 10
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
FD&C YELLOW NO. 6
MAGNESIUM STEARATE
CELLULOSE, MICROCRYSTALLINE
POLYETHYLENE GLYCOL, UNSPECIFIED
POLYVINYL ALCOHOL, UNSPECIFIED
SODIUM BENZOATE
TALC
TITANIUM DIOXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
0536-1247	0536-1247-01, 0536-1247-10

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SENNOSIDES	3FYP5M0IJX	ACTIB
DOCUSATE SODIUM	F05Q2T2JA0	ACTIB
CROSCARMELLOSE SODIUM	M28OL1HH48	IACT
D&C YELLOW NO. 10	35SW5USQ3G	IACT
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE	O7TSZ97GEP	IACT
FD&C YELLOW NO. 6	H77VEI93A8	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
POLYETHYLENE GLYCOL, UNSPECIFIED	3WJQ0SDW1A	IACT
POLYVINYL ALCOHOL, UNSPECIFIED	532B59J990	IACT
SODIUM BENZOATE	OJ245FE5EU	IACT
TALC	7SEV7J4R1U	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Senexon-S	DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG	RUGBY LABORATORIES	2e758ff1-3083-4245-8f58-1c47b042bfdd	2024-12-19	Warnings	Exact identifier ndc (package): 0536-1247-01 ndc (package): 0536-1247-10 ndc (product): 0536-1247 ndc11 (package): 00536124710 ndc11 (package): 00536124701 spl id: 8ff24a4d-d516-4b17-a838-2a61f19686c5 spl set id: 2e758ff1-3083-4245-8f58-1c47b042bfdd

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.